Edgewell Personal Care Company (NYSE:EPC) announced its fourth fiscal quarter and full fiscal year 2026 results on November 12, 2026, covering the period ended September 30, 2026.

Key Highlights

  • Q4 net sales: $484.1 million, up 3.0% versus the prior year quarter, with organic net sales up 3.1%.
  • Q4 Adjusted EPS: $0.78, compared to $0.52 in the prior year quarter, an increase of 50.0%.
  • Full-year net sales: $1,996.5 million, up 1.8%; full-year Adjusted EPS of $1.93, compared to $1.81 in the prior year.
  • Q4 GAAP EPS: $0.23 from continuing operations, compared to $0.26 in the prior year quarter.
  • Cash position: $375.6 million in cash on hand at quarter end, plus $418.8 million available under the U.S. revolving credit facility.
  • Dividend declared: $0.15 per common share, declared by the Board of Directors on November 12, 2026.
  • Adjusted net debt leverage ratio: 3.4x at the end of the fourth quarter.

Edgewell FY2026 Results: Segment Performance and Key Financial Metrics

According to the filing, Edgewell Personal Care's fourth quarter net sales of $484.1 million reflected a $14.2 million increase over the prior year quarter, with currency movements creating a $0.5 million, or 0.1%, unfavorable impact. Organic net sales growth of 3.1% was described as "broad-based," with North America organic sales up 3.3% and International organic sales up 3.0%. Gross profit for the quarter was $209.6 million, up from $188.4 million in the prior year quarter, and adjusted gross margin expanded 510 basis points to 45.7%, driven by productivity savings and favorable volume absorption, partially offset by higher inflation net of tariffs.

The company reported that advertising and sales promotion expense rose to $56.1 million, or 11.6% of net sales, from $45.9 million, or 9.8% of net sales, in the prior year quarter. The filing attributed this increase to continued investment behind focus brands. SG&A was $107.2 million, or 22.1% of net sales, compared to $105.5 million, or 22.5% in the prior year quarter. The company recorded pre-tax restructuring and related costs of $29.9 million in the quarter. Adjusted EBITDA for Q4 was $76.8 million, inclusive of a $6.3 million favorable currency impact, compared to $43.0 million in the prior year quarter.

For the full fiscal year, the filing reported net cash provided by operating activities of $49.6 million on a consolidated basis, compared to $118.4 million in the prior year period. The company stated the decrease was "largely driven by one-time operating cash flow impacts associated directly with the Feminine Care divestiture including tax, working capital, and deal related fees and expenses." The Feminine Care business is treated as discontinued operations throughout the filing. The company also noted it returned $6.9 million to shareholders in the form of dividends during the fourth quarter. The filing stated the company provides a fiscal 2027 outlook expecting growth in organic net sales, Adjusted EBITDA, and Adjusted EPS.

What Was Disclosed

Edgewell disclosed fourth quarter and full fiscal year 2026 financial results, segment-level performance for Wet Shave and Sun and Skin Care, cash position and leverage details, a Q4 dividend declaration of $0.15 per share, and a fiscal 2027 outlook expecting organic net sales growth.